Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Investigator from French National Centre for Scientific Research (CNRS)

Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma

Non-Hodgkin lymphoma

Pathology

Nathaniel Rothman

Studies in the Janus Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Pathology

David Twa

The significance of recurrent translocations involving programmed death ligands in non-Hodgkin lymphomas

Non-Hodgkin lymphoma

Mary Ellen Conley

Genetic Etiology of Agammaglobulinemia with Absent B Cells

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Robert Stanley

Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Kaposi sarcoma Hodgkin lymphoma